Klein Constantin, Michelitsch Anna, Allendorf Valerie, Conraths Franz Josef, Beer Martin, Denzin Nicolai, Wernike Kerstin
Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Transbound Emerg Dis. 2023 Oct 12;2023:1868732. doi: 10.1155/2023/1868732. eCollection 2023.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a pandemic of unprecedented extent. Besides humans, a number of animal species can be infected; however, in some species, differing susceptibilities were observed depending on the virus variant. Here, we serologically investigated cats and dogs living in households with human COVID-19 patients. The study was conducted during the transition period from delta as the dominating variant of concern (VOC) to omicron (BA.1/BA.2) to investigate the frequency of virus transmission of both VOCs from infected owners to their pets. The animal sera were tested by surrogate virus neutralization tests (sVNT) using either the original receptor-binding domain (RBD), enabling the detection of antibodies against the delta variant, or an omicron-specific RBD. Of the 290 canine samples, 20 tested positive by sVNT, but there were marked differences between the sampling time and, related thereto, the virus variants the dogs had contact to. While in November 2021, infected owners led to 50% seropositive dogs (18/36), only 0.8% (2/254) of animals with household contacts to SARS-CoV-2 between December 2021 and April 2022 tested positive. In all cases, the positive reaction was recorded against the original RBD. For cats, a similar pattern was seen, as in November 2021, 38.1% (16/42) tested positive, and between December 2021 and March 2022, only 5.0% (10/199). The markedly reduced ratio of seropositive animals during the period of omicron circulation suggests a considerably lower susceptibility of dogs and cats to this VOC. To examine the effect of further omicron subvariants, sera taken in the second and third quarter of 2022 from randomly selected cats were investigated. 2.3% (11/372) tested seropositive, and all of them showed a stronger reaction against the original RBD, further supporting the assumption of a lower susceptibility of companion animals to the omicron VOC.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发了一场前所未有的大流行。除人类外,一些动物物种也会被感染;然而,在某些物种中,根据病毒变体的不同,观察到了不同的易感性。在此,我们对与人类新冠肺炎患者同住一户的猫和狗进行了血清学调查。该研究在从作为主要关注变体(VOC)的德尔塔变体向奥密克戎(BA.1/BA.2)变体过渡期间进行,以调查这两种VOC从受感染的主人传播给其宠物的频率。使用原始受体结合域(RBD)通过替代病毒中和试验(sVNT)对动物血清进行检测,该原始RBD能够检测针对德尔塔变体的抗体,或者使用奥密克戎特异性RBD进行检测。在290份犬类样本中,有20份通过sVNT检测呈阳性,但采样时间以及与之相关的犬类接触的病毒变体之间存在显著差异。2021年11月,受感染的主人导致50%的犬类血清呈阳性(18/36),而在2021年12月至2022年4月期间,与SARS-CoV-2有家庭接触的动物中只有0.8%(2/254)检测呈阳性。在所有情况下,均记录到针对原始RBD的阳性反应。对于猫来说,也观察到了类似的模式,2021年11月,38.1%(16/42)检测呈阳性,而在2021年12月至2022年3月期间,只有5.0%(10/199)检测呈阳性。在奥密克戎传播期间,血清阳性动物的比例显著降低,这表明猫和狗对该VOC的易感性要低得多。为了研究奥密克戎其他亚变体的影响,对2022年第二和第三季度随机选取的猫的血清进行了调查。2.3%(11/372)检测呈血清阳性,并且所有阳性猫对原始RBD的反应更强,这进一步支持了伴侣动物对奥密克戎VOC易感性较低的假设。